As a proof of principle to validate ribosomes as potential anti-cancer targets, it has been shown that cancer cell proliferation may be inhibited by conditional deletion of the eS6 (S6RP) gene, that globally decreased ribosome function whilst nutrient sensing and growth were unaffected [59]. The gene discussed is RPS6; the disease is cancer.